Edwin C Pratt

Edwin C Pratt

@theprattlab.bsky.social

Assistant Professor of Radiology @Stony Brook Cancer Center. Developer of new theranostics for the detection and elimination of pancreatic and other rare cancers.

15 Followers 25 Following 6 Posts Joined Nov 2024
4 months ago
Postdoctoral Associate Click the link provided to see the complete job description.

The Pratt Lab is looking for a postdoctoral associate to build new theranostics! Apply today and please spread the word if you can! Deadline is Nov 13th so act fast!

stonybrooku.taleo.net/careersectio...

0 0 0 0
4 months ago

Excited to report the Pratt Lab at Stony Brook in their Cancer Center is open! Keep an eye out for hiring notices! Many thanks to @lewislabmskcc.bsky.social for the mentorship during my years at MSKCC. The lab will be focused on chemogenic combinations with theranostics to treat pancreatic cancer.

1 0 0 0
7 months ago
Post image

Happy proofs day to those who celebrate…

Details forthcoming!

#radiopharmaceuticals #theranostics #hcc

7 1 1 1
7 months ago

Excited to share hot off the press our paper outlining a new mesothelin antibody for PET imaging. Many thanks to members of the @lewislabmskcc.bsky.social and Eli Lilly and Co. for making this paper happen!
authors.elsevier.com/c/1lTO73SWXP...

2 0 0 0
10 months ago
Post image Post image

Fantastic talk by fellow @paulklauser.bsky.social at iSRS on covalent binding PET tracers! Brilliant work!

2 0 0 0
11 months ago
Radiances of Cerenkov-Emitting Radionuclides on the In Vivo Imaging System Cerenkov (or Cherenkov) luminescence occurs when charged particles exceed the phase velocity of a given medium. Cerenkov as a modality has gained interest for visualization of numerous radionuclides. ...

Looking to compare brightness between radionuclides? look no further! Radiances of Cerenkov-Emitting Radionuclides on the In Vivo Imaging System. A collection over the years including over 23 radionuclides! @grimmrad.bsky.social and @lewislabmskcc.bsky.social
jnm.snmjournals.org/content/earl...

4 3 0 0
1 year ago
Preview
Pretargeted Trop-2 immunoPET for rapid, selective detection of pancreatic tumors Abstract. Purpose: Recent clinical advances with the approval of antibody-drug conjugates targeting Trop-2 such as sacituzumab-govitecan and datopotomab-deruxtecan have garnered tremendous interest fo...

Out now at Clin Cancer Research we characterized a new Trop-2 antibody for rapid tumor detection in pancreatic, ovarian, and prostate cancers. We also leveraged pretargeting for rapid, high-capacity imaging. Huge thanks to our collaborators for the amazing work!

aacrjournals.org/clincancerre...

1 1 0 0